Weeks 1-4 Starting dose to assess tolerance Weeks 5-8 First dose increase Weeks 9-12 Therapeutic effects begin Weeks 13-16 Approaching target dose Week 17+ Full maintenance dose Side Effects & Safety Most gastrointestinal side effects are mild, temporary, and occur during the dose escalation period
However, in the end, if these changes are not made, true health benefits may not be realized, and the patient would need the medication indefinitely to manage their weight. But the promise is real
Novo Nordisk has begun rolling out the product internationally, with regulatory submissions underway in other regions like Europe and, potentially, future SAHPRA review
Can changing your diet help mute food noise
Podmiotem odpowiedzialnym jest Eli Lilly Polska sp